missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human PDE4A (aa 188-238) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (92%), Rat (92%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-111736 (PA5-111736. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
Cyclic nucleotides are important second messengers that regulate and mediate a number of cellular responses to extracellular signals, such as hormones, light, and neurotransmitters. Cyclic nucleotide phosphodiesterases (PDEs) regulate the cellular concentrations of cyclic nucleotides and thereby play a role in signal transduction. PDE4A is a class IV cAMP-specific PDE.
Specifications
Specifications
| Accession Number | P27815 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 5141 |
| Name | Human PDE4A (aa 188-238) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | cAMP-specific 3',5'-cyclic phosphodiesterase 4 A; cAMP-specific phosphodiesterase PDE4A; cyclic AMP specific phosphodiesterase PDE4A5A; cyclic AMP-specific phosphodiesterase OCPDE4A1A; D9Ertd60e; DPDE2; dunce; LOC100009247; PDE4; PDE46; Pde4a; PHOSA; phosphodiesterase 4 A; phosphodiesterase 4 A, cAMP specific; phosphodiesterase 4 A, cAMP-specific; phosphodiesterase 4 A, cAMP-specific (dunce; phosphodiesterase 4 A, cAMP-specific (phosphodiesterase E2 dunce homolog, Drosophila); phosphodiesterase E2 dunce homolog, Drosophila; phosphodiesterase isozyme 4 |
| Common Name | PDE4A |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction